If this box remains here for more than 30 seconds, click this link to try again.
Industries
Functions
Home » Products & Services » Best Practice Database » Sales Leadership » Sales Training
Metrics, Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Buy Now
Non-members: Click here to sign-up for a complimentary tour of "Meeting Pharmaceutical Sales Rep Training Needs" STUDY OVERVIEW The effectiveness of pharmaceutical sales training during a representative's critical first year on the job dictates the future success of the employee, affects the rate of sales force turnover and directly impacts corporate revenue. Given the diversity and complexity of the subject matter, bringing new reps to full productivity is a huge challenge for pharmaceutical sales training leaders. This means that the executives designing such formal training programs must be able to identify what makes a program successful and direct the appropriate level of budget resources to meet those needs. Formal training is training that is required and tracked by the employer, including assigned readings as well as classes, computer-based courses, e-learning, etc. This research can help pharmaceutical sales training leaders identify not only the content that is most effective in training but also the qualifications needed in applicants to best take advantage of the training investment as well as compare their budget and outsourcing metrics to those with other companies. KEY TOPICS
Industries Profiled: Pharmaceutical; Health Care; Medical Device; Biotech; Manufacturing; Consumer Products; Diagnostic Companies Profiled: Merck; Sanofi-aventis; Roche; Fournier Pharmaceutical; Abbott Laboratories; Novartis; GlaxoSmithKline; Pfizer; Johnson & Johnson; Schering-Plough; Medrad; Bristol-Myers Squibb; Amylin; Bayer; UCB Pharma; AstraZeneca Pharmaceuticals
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.
Top